Abstracts

Parsons SK, Lerner D, Rodday AM, Curtis R, Kelly K, Conti R, Castellino SM, Henderson TO. Parental Work Limitations at Diagnosis of Advanced Stage Pediatric Hodgkin Lymphoma (HL): Results of Caregiver Work Limitations Questionnaire (CG WLQ). Journal of Clinical Oncology. 2018; 36(15 suppl): e18927-e18927.

1

Parsons SK, Kelly MJ, Cohen JT, Catellino SM, Henderson TO, Kelly KM, Keller FG, Henzer TJ, Kumar AJ, Johnson P, Meyer RM, Radford J, Raemaekers J, Hodgson DC, Evens AM. Early-stage Hodgkin Lymphoma in the Modern era: Simulation Modeling to Delineate Long-term Patient Outcomes. Presentation at International Symposium on Hodgkin Lymphoma. Cologne, Germany. October 2018.

2

Kumar AJ, Chun CR, Rodday AM, Cannizzaro NT, Rodriguez RR, Evens AM, Feliciano J, SK Parsons SK. Patterns and Outcomes with Salvage Treatment for Hodgkin Lymphoma (HL): Real-World Analysis from the Community Oncology Setting. Presentation at International Symposium on Hodgkin Lymphoma. Cologne, Germany. October 2018.

3

Rodday AM, Parsons SK, Bush R, Pei Q, Curtis R, Keller F, Kelly K, Henderson T, Castellino SM. Health-Related Quality of Life (HRQL) Trajectories during Treatment for Advanced Stage Pediatric Hodgkin Lymphoma (HL). Presentation at International Symposium on Hodgkin Lymphoma. Cologne, Germany. October 2018.

4

Chao C, Xu L, Canizarro NT, Rodday AM, Feliciano J, Kumar AJ, Evens AM, Parsons SK. The Development and Validation of an Electronic health record (EHR)-based Algorithm for Identifying Treatment Failure in Newly Diagnosed Hodgkin lymphoma (HL) treated in a US Community Oncology Setting. Presentation at 60th American Society of Hematology (ASH) Annual Meeting & Exposition. San Diego, CA. December 2018. Blood, 132(Suppl 1), 2261-2261. doi: 10.1182/blood-2018-99-112225.

5

Waheed A, Rodday AM, Kumar AJ, Miller K, Parsons SK. Hematopoietic Stem Cell Transplant Utilization in Relapsed/Refractory HL: A Population Level Analysis of Statewide Claims Data. Blood, 132(Suppl 1), 4771-4771. doi: 10.1182/blood-2018-99-111921. Presentation at 60th American Society of Hematology (ASH) Annual Meeting & Exposition. San Diego, CA. December 2018.

6

Parsons SK, Castellino SM, Rodday AM, Keller F, Curtis R, Kelly K, Conti R, Lerner D, Henderson TO. Productivity loss among parent caregivers is associated with poor health related quality of life (HRQL) at the time of the initial diagnosis of advanced stage Hodgkin Lymphoma (HL). Oral Presentation at 60th American Society of Hematology (ASH) Annual Meeting & Exposition. San Diego, CA. December 2018. Blood, 132(Suppl 1), 975-975. doi: 10.1182/blood-2018-99-117316.

7

Parsons SK, Rodday AM, Bush R, Pei Q, Curtis R, Keller F, Kelly K, Henderson T, Castellino SM. Health-Related Quality of Life (HRQL) Trajectories during Treatment for Advanced Stage Pediatric Hodgkin Lymphoma (HL). Presentation at 60th American Society of Hematology (ASH) Annual Meeting & Exposition. San Diego, CA. December 2018. Blood, 132(Suppl 1), 3587-3587. doi: 10.1182/blood-2018-99-112664.

8

Rodday AM, Hahn T, Lindenauer PK, Friedberg J, Evens AM, Parsons SK. Disparities in First-line Treatment of Elderly Patients with Hodgkin Lymphoma: An Analysis of Surveillance, Epidemiology and End Results (SEER)-Medicare Data. Accepted for presentation at Academy Health 2019 Annual Research Meeting. Washington, DC. June 2019.

9

Castellino SM, Rodday AM, Pei Q, Bush R, Keller FG, Henderson TO, Kelly KM, Cella D, Parsons SK. Performance of FACT-GOG-Ntx to Assess Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Pediatric Hodgkin Lymphoma (HL) Patients. Accepted for presentation at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. Chicago, IL. June 2019.

10

Rodday AM, Hahn T, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK. The role of frailty and comorbidity in treatment (tx) of elderly patients with Hodgkin lymphoma (HL). Accepted for online publication at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. Chicago, IL. June 2019.

11

Castellino SM, Rodday AM, Pei Q, Bush R, Keller FG, Henderson TO, Kelly KM, Cella D, Parsons SK. Performance of FACT-GOG-Ntx to Assess Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Pediatric Hodgkin Lymphoma (HL) Patients. Accepted for presentation at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. Chicago, IL. June 2019.

12

Rodday AM, Hahn TE, Kumar AJ, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK. Treatment with Full Chemotherapy Regimens in Older Adults with Hodgkin Lymphoma Improves 3-Year Overall Survival, but Less Than Half Receive Full Regimens. Blood. 2019;134(Supplement_1):1563-. doi: 10.1182/blood-2019-124141.

13

Kumar AJ, Murphy-Banks R, Weidner RA, Parsons SK. Late Effects Are Important Considerations in Initial Hodgkin Lymphoma Treatment Decision-Making According to Survivors. Blood. 2019;134(Supplement_1):2137-. doi: 10.1182/blood-2019-124481.

14

Parsons SK, Rodday AM, Scharman C, Andre M, Federico M, Friedberg FW, Friedman DL, Gallamini A, Hay AE, Hoskin P, Johnson P, Kahl BS, Keller FG… Evens AM. The Hodgkin lymphoma international study for individual care (HoLISTIC): Enhancing decision making in pediatric and adult Hodgkin lymphoma (HL). Accepted at the American Society of Clinical Oncology Meeting, June 2020. 

15

Parsons SK, Bhakta N, Rodday AM, Scharman C, Andre M, Federico M, Friedberg JW, Friedman DL, Gallamini A, Hay AE, Kahl BS, Keller FG, Kelly KM, Meyer RM… Evens AM. Lifelong disease burden of chemotherapy in Hodgkin lymphoma (HL): A simulation study from the St. Jude Lifetime (SJLIFE) Cohort and HL International Study for Individual Care (HoLISTIC). Accepted at the American Society of Clinical Oncology Meeting, June 2020.

16

Castellino SM, LeBlanc ML, Herrera AF, Parsons SK, Punnet, A, Hodgson DC, Rutherford SC, Khan N, Constine LS, Davison K, Prica AA, Friedberg FW, Kelly, KM. An intergroup collaboration for advanced stage classical Hodgkin lymphoma (cHL) in adolescents and young adults (AYA): SWOG S1826. Accepted at the American Society of Clinical Oncology Meeting, June 2020. 

17

Rodday AM, Hahn T, Kumar AJ, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK. The Role of Immortal Time Bias in Assessing the Relationship between Treatment Intensity and Survival in Hodgkin Lymphoma: An Analysis of Surveillance, Epidemiology and End Result (SEER) Medicare Data.

18

Accepted at Academy Health Annual Research Meeting, June 2020

Evens A, Advani R, Aleman B, Andre M, Bhakta N, Cardoso M, Castellino S, Cerhan J, Chao C, Cohen J, Cole P, Engert A, Federico M, Figueroa L, Flerlage J, Flowers C… Parsons SK. The Hodgkin lymphoma international study of individual care (HoLISTIC): Enhancing decision making in pediatric and adult Hodgkin lymphoma (HL).

19

Accepted at Congress of the European Hematology Association Meeting, June 2020

Copyright © Hodgkin Lymphoma International Study for Individual Care